Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Axe Compute Inc stock logo
AGPU
Axe Compute
$10.66
+28.9%
$7.49
$1.03
$32.10
$122.48M3.441.57 million shs2.21 million shs
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
$22.39
+7.0%
$21.40
$3.01
$30.00
$79.71M1248,693 shs69,150 shs
Zenvia Inc. stock logo
ZENV
Zenvia
$0.47
$0.47
$0.25
$1.90
$24.35M1.86123,570 shsN/A
Zentek Ltd. stock logo
ZTEK
Zentek
$0.60
-1.5%
$0.51
$0.37
$1.24
$76.09M0.43212,301 shs87,835 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Axe Compute Inc stock logo
AGPU
Axe Compute
0.00%-1.55%+20.38%+76.71%+826,999,900.00%
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
0.00%0.00%-20.81%+32.22%+566.56%
Zenvia Inc. stock logo
ZENV
Zenvia
0.00%0.00%0.00%0.00%-71.37%
Zentek Ltd. stock logo
ZTEK
Zentek
0.00%-8.31%+29.78%-17.55%-19.72%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Axe Compute Inc stock logo
AGPU
Axe Compute
$10.66
+28.9%
$7.49
$1.03
$32.10
$122.48M3.441.57 million shs2.21 million shs
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
$22.39
+7.0%
$21.40
$3.01
$30.00
$79.71M1248,693 shs69,150 shs
Zenvia Inc. stock logo
ZENV
Zenvia
$0.47
$0.47
$0.25
$1.90
$24.35M1.86123,570 shsN/A
Zentek Ltd. stock logo
ZTEK
Zentek
$0.60
-1.5%
$0.51
$0.37
$1.24
$76.09M0.43212,301 shs87,835 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Axe Compute Inc stock logo
AGPU
Axe Compute
0.00%-1.55%+20.38%+76.71%+826,999,900.00%
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
0.00%0.00%-20.81%+32.22%+566.56%
Zenvia Inc. stock logo
ZENV
Zenvia
0.00%0.00%0.00%0.00%-71.37%
Zentek Ltd. stock logo
ZTEK
Zentek
0.00%-8.31%+29.78%-17.55%-19.72%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Axe Compute Inc stock logo
AGPU
Axe Compute
1.00
SellN/AN/A
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
1.50
Reduce$6.00-73.20% Downside
Zenvia Inc. stock logo
ZENV
Zenvia
1.00
SellN/AN/A
Zentek Ltd. stock logo
ZTEK
Zentek
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest ZENV, AGPU, ZTEK, and CHRN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2026
Zentek Ltd. stock logo
ZTEK
Zentek
Reiterated RatingSell (E+)
6/1/2026
Axe Compute Inc stock logo
AGPU
Axe Compute
UpgradeSell (E+)Sell (D-)
(Data available from 8/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Axe Compute Inc stock logo
AGPU
Axe Compute
$120K1,020.70N/AN/A$11.69 per share0.91
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
$12.80M6.23N/AN/A$3.44 per share6.51
Zenvia Inc. stock logo
ZENV
Zenvia
$1.10B0.02N/AN/A$2.75 per share0.17
Zentek Ltd. stock logo
ZTEK
Zentek
$120K634.05N/AN/A$0.07 per share8.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Axe Compute Inc stock logo
AGPU
Axe Compute
-$233.10M-$8.18N/AN/AN/A-7,769.61%-5,090.33%-530.79%N/A
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
-$11.69M-$5.38N/AN/AN/A-135.66%-197.81%-74.17%N/A
Zenvia Inc. stock logo
ZENV
Zenvia
-$28.67M-$0.40N/A23.45N/A-10.62%-14.36%-6.52%N/A
Zentek Ltd. stock logo
ZTEK
Zentek
-$7.07M-$0.07N/AN/AN/A-5,848.76%-92.93%-63.71%N/A

Latest ZENV, AGPU, ZTEK, and CHRN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Axe Compute Inc stock logo
AGPU
Axe Compute
N/A-$0.87N/A-$0.87N/A$3.21 million
8/14/2026Q1 2027
Zentek Ltd. stock logo
ZTEK
Zentek
-$0.0240-$0.01+$0.0140-$0.01$0.24 millionN/A
6/30/2026Q2 2026
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
N/A-$3.8930N/A-$3.8930N/A$18.09 million
6/25/2026Q4 2026
Zentek Ltd. stock logo
ZTEK
Zentek
-$0.0239-$0.03-$0.0061-$0.03$0.24 million$0.03 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Axe Compute Inc stock logo
AGPU
Axe Compute
N/AN/AN/AN/AN/A
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
N/AN/AN/AN/AN/A
Zenvia Inc. stock logo
ZENV
Zenvia
N/AN/AN/AN/AN/A
Zentek Ltd. stock logo
ZTEK
Zentek
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Axe Compute Inc stock logo
AGPU
Axe Compute
N/A
8.89
8.89
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
0.25
1.55
1.03
Zenvia Inc. stock logo
ZENV
Zenvia
0.02
0.38
0.38
Zentek Ltd. stock logo
ZTEK
Zentek
0.18
0.64
0.53

Institutional Ownership

CompanyInstitutional Ownership
Axe Compute Inc stock logo
AGPU
Axe Compute
9.04%
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
6.42%
Zenvia Inc. stock logo
ZENV
Zenvia
49.25%
Zentek Ltd. stock logo
ZTEK
Zentek
0.77%

Insider Ownership

CompanyInsider Ownership
Axe Compute Inc stock logo
AGPU
Axe Compute
1.21%
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
6.90%
Zenvia Inc. stock logo
ZENV
Zenvia
78.37%
Zentek Ltd. stock logo
ZTEK
Zentek
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Axe Compute Inc stock logo
AGPU
Axe Compute
1311.49 million11.36 millionN/A
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
603.56 million3.32 millionNo Data
Zenvia Inc. stock logo
ZENV
Zenvia
1,08051.94 million11.23 millionNot Optionable
Zentek Ltd. stock logo
ZTEK
Zentek
24126.62 millionN/ANot Optionable

Recent News About These Companies

Cours Zentek Ltd. Nasdaq
Zentek Ltd. Common Stock (ZTEK)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Axe Compute stock logo

Axe Compute NASDAQ:AGPU

$10.66 +2.39 (+28.90%)
As of 02:51 PM Eastern

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.

ChronoScale Corporation Common Stock stock logo

ChronoScale Corporation Common Stock NASDAQ:CHRN

$22.39 +1.46 (+6.98%)
As of 02:51 PM Eastern

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Zenvia stock logo

Zenvia NASDAQ:ZENV

$0.47 0.00 (0.00%)
As of 08/14/2026

Zenvia Inc. provides customer experience communications platform which empowers businesses to create unique journeys for their end-customers along their life cycle across range of B2C verticals. Zenvia Inc. is based in S?O PAULO.

Zentek stock logo

Zentek NASDAQ:ZTEK

$0.60 -0.01 (-1.51%)
As of 02:51 PM Eastern

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.